Resources
Big Molecule Watch
- Alvotech Announces Positive Topline Results From Confirmatory Clinical Study for its Proposed Golimumab Biosimilar April 26, 2024 Timothy Beavers
- FDA Approval of Alvotech/Teva Ustekinumab Biosimilar April 23, 2024 Seth Manilove
- DOJ Files False Claims Act Complaint Against Regeneron, Alleging Fraudulent Eylea Drug Pricing April 22, 2024 Grace Truong
- Federal Circuit Dismisses Appeals in Regeneron v. Mylan (Aflibercept) BPCIA Litigation April 22, 2024 Grace Truong
- Fresenius Kabi Announces Launch of TYENNE, a Tocilizumab Biosimilar Referencing ACTEMRA April 19, 2024 Sam Herron
- Genentech and Dr. Reddy’s Settle BPCIA Rituximab Litigation April 18, 2024 Alison Siedor
- MDL Panel Grants Transfer of Aflibercept BPCIA Case April 17, 2024 Yoko Bian
- FDA Approves BMS and J&J CAR-T Cell Therapies for the Earlier Treatment of Multiple Myeloma April 11, 2024 Beth Ashbridge
- Janssen v. Teva: Not an April Fool’s Day Joke for Life Sciences Companies April 9, 2024 Stephanie Dusaban Gonzales|Sabrina Poulos
- FDA Approves New Indication for AstraZeneca and Daiichi Sankyo’s Cancer Drug ENHERTU April 9, 2024 Emma Murray
BioPharma Reporter
- Jetted resin revolution: Purolite's biopharma breakthroughs April 26, 2024
- AstraZeneca’s Lynparza to remain dominant in PARP inhibitors market with $4 billion in sales by 2027 April 25, 2024
- University of Dundee spin-out bags £4m to develop active biologic drugs April 25, 2024
- Inizio Engage: Elevating healthcare product launches through smart data April 25, 2024
- Karen Ooms' keen interest in Schrodinger's Cat and how it led to a 35-year career in science April 24, 2024
- FDA approves Takeda’s self-administered Entyvio for Crohn’s disease April 23, 2024
- CN Bio raises $21 million to scale up organ-on-a-chip technology April 23, 2024
- Could placenta-derived cells revolutionize age-related disease treatment? April 23, 2024
- Quotient Sciences new platform disrupts conventional drug development processes April 23, 2024
- How Biosynth is coming to CPHI North America with an 'even bigger toolbox' April 22, 2024